Anthracyclines for gestational breast cancer: course and outcome of pregnancy.
Azim
H A
HA
Department of Medicine, European Institute of Oncology.
Peccatori
F A
FA
Department of Medicine, European Institute of Oncology. Electronic address: fedro.peccatori@ieo.it.
Scarfone
G
G
Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.
Acaia
B
B
Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.
Rossi
P
P
Division of Obstetrics and Gynaecology, IRCCS Policlinico, Mangiagalli and Regina Elena, University of Milan, Milan, Italy.
Cascio
R
R
Department of Medicine, European Institute of Oncology.
Goldhirsch
A
A
Department of Medicine, European Institute of Oncology.
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D006801:Humans; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic / Q000188:drug therapy*; D011256:Pregnancy Outcome
D015251:Epirubicin; D004317:Doxorubicin